Log In
BCIQ
Print this Print this
 

TP-0413

  Manage Alerts
Collapse Summary General Information
Company Tolero Pharmaceuticals Inc.
DescriptionSmall molecule inhibitor of the janus kinase-2 (JAK-2) and bone morphogenetic protein (BMP) signaling pathways
Molecular Target Janus kinase-2 (JAK-2)
Mechanism of ActionJanus kinase-2 (JAK-2) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAnemia
Indication DetailsTreat anemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$780.0M

$200.0M

$580.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/21/2016

$780.0M

$200.0M

$580.0M

Get a free BioCentury trial today